Page last updated: 2024-10-29

ifosfamide and Infection, Toxoplasma gondii

ifosfamide has been researched along with Infection, Toxoplasma gondii in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Our results found that Toxoplasma gondii infection in the brain increases SOCS3 expression and decreases the phosphorylation of STAT3, resulting in reducing IL-17A and IL-23, which suppress the differentiation and expansion of pathogenic Th17 cells, an important factor in MS development."1.62Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3. ( Ham, DW; Kim, SG; Lee, SH; Seo, SH; Shin, EH; Shin, JH, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ham, DW1
Kim, SG1
Seo, SH1
Shin, JH1
Lee, SH1
Shin, EH1

Other Studies

1 other study available for ifosfamide and Infection, Toxoplasma gondii

ArticleYear
Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021, Volume: 18, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Brain; Cisplatin; Enceph

2021